Durect Corporation (DRRX) - Total Assets
Based on the latest financial reports, Durect Corporation (DRRX) holds total assets worth $12.48 Million USD as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Durect Corporation - Total Assets Trend (1999–2024)
This chart illustrates how Durect Corporation's total assets have evolved over time, based on quarterly financial data. Also see DRRX market cap overview for the company's overall valuation and market capitalisation.
Durect Corporation - Asset Composition Analysis
Current Asset Composition (December 2024)
Durect Corporation's total assets of $12.48 Million consist of 71.8% current assets and 28.2% non-current assets. Review how much debt does Durect Corporation carry to assess the company's total debt and financial obligations.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 60.0% |
| Accounts Receivable | $453.00K | 2.5% |
| Inventory | $106.00K | 0.6% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $2.73 Million | 14.9% |
Asset Composition Trend (1999–2024)
This chart illustrates how Durect Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See latest Durect Corporation stock price today for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Durect Corporation's current assets represent 71.8% of total assets in 2024, a decrease from 77.8% in 1999.
- Cash Position: Cash and equivalents constituted 60.0% of total assets in 2024, up from 17.2% in 1999.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 14.0% of total assets, an increase from 6.0% in 1999.
- Asset Diversification: The largest asset category is goodwill at 14.9% of total assets.
Durect Corporation Competitors by Total Assets
Key competitors of Durect Corporation based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Kamada
TA:KMDA
|
Israel | ILA377.21 Million |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
|
USA | $15.42 Trillion |
|
Viatris Inc
NASDAQ:VTRS
|
USA | $35.04 Billion |
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
Germany | €15.41 Trillion |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
|
China | CN¥14.18 Billion |
|
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773
|
China | CN¥10.21 Billion |
|
Yipinhong Pharmaceutical Co Ltd Class A
SHE:300723
|
China | CN¥4.49 Billion |
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
USA | $199.45 Million |
Durect Corporation - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.98 | 0.91 | 5.95 |
| Quick Ratio | 0.95 | 0.80 | 5.57 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-121.00K | $-1.98 Million | $47.31 Million |
Durect Corporation - Advanced Valuation Insights
This section examines the relationship between Durect Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 17.03 |
| Latest Market Cap to Assets Ratio | 3.23 |
| Asset Growth Rate (YoY) | -59.4% |
| Total Assets | $18.35 Million |
| Market Capitalization | $59.31 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Durect Corporation's assets at a significant premium (3.23x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Durect Corporation's assets decreased by 59.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Durect Corporation (1999–2024)
The table below shows the annual total assets of Durect Corporation from 1999 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $18.35 Million | -59.39% |
| 2023-12-31 | $45.19 Million | -24.81% |
| 2022-12-31 | $60.10 Million | -34.67% |
| 2021-12-31 | $91.99 Million | +21.61% |
| 2020-12-31 | $75.64 Million | -12.07% |
| 2019-12-31 | $86.02 Million | +72.04% |
| 2018-12-31 | $50.00 Million | -5.86% |
| 2017-12-31 | $53.11 Million | +31.12% |
| 2016-12-31 | $40.51 Million | -13.39% |
| 2015-12-31 | $46.77 Million | -6.61% |
| 2014-12-31 | $50.08 Million | +22.69% |
| 2013-12-31 | $40.82 Million | -11.14% |
| 2012-12-31 | $45.94 Million | -6.63% |
| 2011-12-31 | $49.20 Million | -27.18% |
| 2010-12-31 | $67.56 Million | +16.18% |
| 2009-12-31 | $58.15 Million | -22.33% |
| 2008-12-31 | $74.87 Million | -10.89% |
| 2007-12-31 | $84.02 Million | -18.02% |
| 2006-12-31 | $102.48 Million | -12.71% |
| 2005-12-31 | $117.41 Million | +37.38% |
| 2004-12-31 | $85.47 Million | -23.97% |
| 2003-12-31 | $112.41 Million | +54.04% |
| 2002-12-31 | $72.97 Million | -30.47% |
| 2001-12-31 | $104.94 Million | -12.99% |
| 2000-12-31 | $120.61 Million | +436.94% |
| 1999-12-31 | $22.46 Million | -- |
About Durect Corporation
DURECT Corporation, a biopharmaceutical company, develops medicines based on its epigenetic regulator program. The company's lead product candidate includes larsucosterol, an endogenous, orally bioavailable small molecule to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as for the treatment… Read more